A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Zepbound, chemically known as tirzepatide, is the newest weight loss medication approved by the FDA. Originally approved for Type 2 diabetes under the brand name Mounjaro, Zepbound has generated a ...

Last year, Eli Lilly announced a new website allowing patients to get a prescription for weight loss through a telehealth ... Health members prescribed Zepbound by their provider will have the ...

Raw HTML : Diets Table – Best Weight Loss Zepbound, chemically known as tirzepatide, is the newest weight loss medication approved by the FDA. Originally approved for Type 2 diabetes under the ...

Eli Lilly lowered the price of two dosage levels of its weight-loss drug Zepbound for patients paying out of pocket. The company also launched new 7.5-mg and 10-mg single-use vials, which cost $ ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Eli Lilly has reduced the prices of certain ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...

Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower doses in vials in August.

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their medications elsewhere.

Eli Lilly is lowering the cost barrier to its weight loss drug Zepbound. For many consumers, their insurance denies them coverage for weight loss drugs. Now, for those who have to pay out-of ...

New pricing aims to attract cash-paying customers via LillyDirect Hims & Hers warns it may stop selling compounded version of Novo Nordisk weight-loss drugs ... of Lilly's Zepbound and Novo's ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...